|
MYSM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.669800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.636000E-01 |
| Normal-vs-Stage2 |
5.152000E-01 |
| Normal-vs-Stage3 |
6.437300E-03 |
| Normal-vs-Stage4 |
7.334800E-01 |
| Stage1-vs-Stage2 |
9.582600E-01 |
| Stage1-vs-Stage3 |
2.947600E-02 |
| Stage1-vs-Stage4 |
9.643000E-01 |
| Stage2-vs-Stage3 |
2.245400E-01 |
| Stage2-vs-Stage4 |
9.504800E-01 |
| Stage3-vs-Stage4 |
6.329000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.656600E-01 |
| Normal-vs-AfricanAmerican |
4.246800E-01 |
| Normal-vs-Asian |
3.379500E-02 |
| Caucasian-vs-AfricanAmerican |
8.923200E-01 |
| Caucasian-vs-Asian |
1.114470E-02 |
| AfricanAmerican-vs-Asian |
1.220360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.084630E-01 |
| Normal-vs-Female |
7.262600E-01 |
| Male-vs-Female |
2.891700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.405800E-01 |
| Normal-vs-Extreme_Weight |
5.334400E-02 |
| Normal-vs-Obese |
5.943000E-01 |
| Normal-vs-Extreme_Obese |
4.736400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.943000E-01 |
| Normal_Weight-vs-Obese |
8.952400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.581200E-01 |
| Extreme_Weight-vs-Obese |
1.611200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.703600E-01 |
| Obese-vs-Extreme_Obese |
7.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.489200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.342400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.286360E-01 |
| Normal-vs-Age(81-100Yrs) |
6.560800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.802400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.780400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.633600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.478300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.954200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.198820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.639800E-01 |
| Normal-VS-Type2 PRCC |
2.678400E-02 |
| Normal-VS-KIRP CIMP |
2.163200E-01 |
| Normal-VS-Unclassified PRCC |
7.478800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.162300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.451000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.689400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.628600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.019500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.022000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.639300E-03 |
| Normal-vs-N1 |
6.085800E-01 |
| Normal-vs-N2 |
1.238610E-01 |
| N0-vs-N1 |
2.972200E-01 |
| N0-vs-N2 |
6.752000E-01 |
| N1-vs-N2 |
5.217800E-01 |
|
|
